| Janie J. Gendron, Lcsw, Pllc | |
|
1 Varrell Ln Ste 18 York ME 03909-1058 | |
| (207) 337-1778 | |
| Not Available |
| Full Name | Janie J. Gendron, Lcsw, Pllc |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 1 Varrell Ln Ste 18, York, Maine |
| Authorized Official Name and Position | Janie Gendron (OWNER) |
| Authorized Official Contact | 2073371778 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Janie J. Gendron, Lcsw, Pllc 427 Cider Hill Rd York ME 03909-5306 Ph: (207) 337-1778 | Janie J. Gendron, Lcsw, Pllc 1 Varrell Ln Ste 18 York ME 03909-1058 Ph: (207) 337-1778 |
| NPI Number | 1235845983 |
|---|---|
| Provider Enumeration Date | 01/26/2023 |
| Last Update Date | 01/26/2023 |
| Certification Date | 01/26/2023 |
| Medicare PECOS PAC ID | 6305218488 |
|---|---|
| Medicare Enrollment ID | O20230220000222 |
News Archive
Less than a decade ago, the U.S. Department of Defense established the Armed Forces Institute of Regenerative Medicine I with a multimillion dollar grant to focus research centered on regenerative medicine for the treatment of battlefield injuries and selected Rutgers University-New Brunswick to lead the civilian research program.
Immunotec Inc. announced today the enrollment of the first patient in the US Cancer trial of IMN 1207 being run at Beaumont Hospital's Community Clinical Oncology Program (CCOP) in Royal Oak, Michigan. The goal of the study is to determine the effect of IMN 1207, a cysteine-rich whey protein supplement, in preventing additional weight loss in patients with stage IV (advanced) non-small cell lung cancer.
EpiCept Corporation today announced that the targeted enrollment in a Phase IIb trial for EpiCept NP-1 in chemotherapy-induced peripheral neuropathy has been attained. The trial is being conducted by National Cancer Institute -funded Community Clinical Oncology Program.
The Bend Memorial Clinic is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. Specifically, the trial is evaluating the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235845983 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
| Provider Name | Janie James Gendron |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1750607164 PECOS PAC ID: 9234174400 Enrollment ID: I20050628000503 |
News Archive
Less than a decade ago, the U.S. Department of Defense established the Armed Forces Institute of Regenerative Medicine I with a multimillion dollar grant to focus research centered on regenerative medicine for the treatment of battlefield injuries and selected Rutgers University-New Brunswick to lead the civilian research program.
Immunotec Inc. announced today the enrollment of the first patient in the US Cancer trial of IMN 1207 being run at Beaumont Hospital's Community Clinical Oncology Program (CCOP) in Royal Oak, Michigan. The goal of the study is to determine the effect of IMN 1207, a cysteine-rich whey protein supplement, in preventing additional weight loss in patients with stage IV (advanced) non-small cell lung cancer.
EpiCept Corporation today announced that the targeted enrollment in a Phase IIb trial for EpiCept NP-1 in chemotherapy-induced peripheral neuropathy has been attained. The trial is being conducted by National Cancer Institute -funded Community Clinical Oncology Program.
The Bend Memorial Clinic is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. Specifically, the trial is evaluating the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
› Verified 9 days ago
News Archive
Less than a decade ago, the U.S. Department of Defense established the Armed Forces Institute of Regenerative Medicine I with a multimillion dollar grant to focus research centered on regenerative medicine for the treatment of battlefield injuries and selected Rutgers University-New Brunswick to lead the civilian research program.
Immunotec Inc. announced today the enrollment of the first patient in the US Cancer trial of IMN 1207 being run at Beaumont Hospital's Community Clinical Oncology Program (CCOP) in Royal Oak, Michigan. The goal of the study is to determine the effect of IMN 1207, a cysteine-rich whey protein supplement, in preventing additional weight loss in patients with stage IV (advanced) non-small cell lung cancer.
EpiCept Corporation today announced that the targeted enrollment in a Phase IIb trial for EpiCept NP-1 in chemotherapy-induced peripheral neuropathy has been attained. The trial is being conducted by National Cancer Institute -funded Community Clinical Oncology Program.
The Bend Memorial Clinic is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. Specifically, the trial is evaluating the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
› Verified 9 days ago
Anne M Merra Md Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 10 Market Place Dr, York, ME 03909 Phone: 207-337-3257 | |
Lighthouse Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 266 York St Ste 3, York, ME 03909 Phone: 207-361-3036 | |
Neurology Associates Of York Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 233 York St, Ste A, York, ME 03909 Phone: 207-351-3987 Fax: 207-351-3478 | |
York Neurology, P. A. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 233 York St, Suite A, York, ME 03909 Phone: 207-363-8700 Fax: 207-351-3478 | |
Tide Meadow Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1132 Route 1 Suite 5, York, ME 03909 Phone: 207-450-6565 | |
Audrey J Yeaton Psychotherapy, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 433 Us Route 1, Suite 215, York, ME 03909 Phone: 207-337-5507 | |
Roots & Riptides Psychotherapy Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4 Market Place Dr Ste 201d, York, ME 03909 Phone: 207-994-9453 Fax: 207-221-1711 |